Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation

Human Pathology

Volumn 44, Issue 12, 2013, Pages 2636-2642

  Ichinokawa, Hideomi ^a,b   Ishii, Genichiro ^a   Nagai, Kanji ^b   Kawase, Akikazu ^b   Yoshida, Junji ^b   Nishimura, Mitsuyo ^b   Hishida, Tomoyuki ^b   Ogasawara, Naomi ^b   Tsuchihara, Katsuya ^b   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Epidermal growth factor receptor (EGFR); KRAS; Mucinous adenocarcinoma

Indexed keywords

GEMININ; KALININ; MATRILYSIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG MUCINOUS ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS;

EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR); KRAS; MUCINOUS ADENOCARCINOMA;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES; FEMALE; GEMININ; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84888067635     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.05.026     Document Type: Article

References (34)

1. Y. Shimosato, T. Kodama, and T. Kameya Morphogenesis of peripheral type adenocarcinoma of the lung Y. Shimosato, M.R. Melamed, P. Nettesheim, Morphogenesis of Lung Cancer Vol. 1 1982 CRC Press Boca Raton 65 89
2. Y. Kimula A histochemical and ultrastructural study of adenocarcinoma of the lung Am J Surg Pathol 2 1978 253 264
3. W.D. Travis, E. Brambilla, and M. Noguchi International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma J Thorac Oncol 6 2011 244 285
4. H. Ichinokawa, G. Ishii, and K. Nagai Clinicopathological characteristics of primary lung adenocarcinoma predominantly composed of goblet cells in surgically resected cases Pathol Int 6 2011 423 429
5. M. Wislez, M. Antoine, and L. Baudrin Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib Lung Cancer 68 2010 185 191
6. J. Cadranel, E. Quoix, and L. Baudrin IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype J Thorac Oncol 4 2009 1126 1135
7. H.L. West, J.J. Crowley, and R.B. Vance Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96 hour infusion (SWOG 9714): a Southwest Oncology Group Study Ann Oncol 16 2005 1076 1080
8. T. Kobayashi, H. Tsuda, and M. Noguchi Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes Cancer 66 1990 289 294
9. G.J. Riely, J. Marks, and W. Pai KRAS mutations in non-small cell lung cancer Proc Am Thorac Soc 6 2009 201 205
10. Y. Sakuma, S. Matsukuma, and M. Yoshihara Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinoma in EGFR and KRAS gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations Am J Clin Pathol 128 2007 100 108
11. M. Suzuki, H. Shigematsu, and T. Iizaka Exclusive mutation in epidermal growth factor receptor gene, HER-2 and KRAS, and synchronous methylation of non-small cell lung cancer Cancer 106 2006 2200 2207
12. I.Y. Tam, L.P. Chung, and W.S. Suen Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features Clin Cancer Res 12 2006 1647 1653
13. D. Pham, M.G. Kris, and G.J. Riely Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas J Clin Oncol 24 2006 1700 1704
14. V.A. Miller, M.G. Kris, and N. Shah Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small cell lung cancer J Clin Oncol 22 2004 1103 1109
15. A. Marchetti, C. Martella, and L. Felicioni EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment J Clin Oncol 23 2005 857 865
16. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, and C.C. Harris WHO Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart 2004 IARC Press Lyon
17. Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract. Atlas of Tumor Pathology. Vol. 3. Washington DC: Armed Forces Institute of, Pathology; 1995. p. 203-34.
18. W.D. Travis, T.V. Colby, and B. Corrin WHO Classification of Tumours. Histological Type of Lung and Pleural Tumours. 3rd ed 1999 Springer-Verlag Berlin
19. A.A. Leibow Bronchiolo-alveolar carcinoma Adv Intern Med 10 1960 329 358
20. S. Okada, Y. Ebihara, and J. Yoneyama Mucin-producing bronchioloalveolar carcinoma Jpn J Lung Cancer Clin 2 1999 317 322
21. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of Malignant Tumours J Thorac Oncol 2 2007 706 714
22. K. Aokage, G. Ishii, and Y. Ohataki Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation Int J Cancer 128 2011 1585 1595
23. C.S. Karapetics, S. Khambata-Ford, and D.J. Jonker KRAS mutations and benefit from cetuximab in advanced colorectal cancer N Engl J Med 359 2008 1757 1765
24. H. Shigematsu, L. Lin, and T. Takahashi Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers J Natl Cancer Inst 97 2005 339 346
25. H. Bando, K. Tsuchihara, and T. Yoshino Biased discordance of KRAS mutation detection in archived colorectal cancer specimens between the ARMS-Scorpion method and direct sequencing Jpn J Clin Oncol 41 2011 239 244
26. A. Hata, N. Katakami, and S. Fujita Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma J Thorac Oncol 5 2010 1197 1200
27. H. Kitamura, Y. Kameda, T. Ito, and H. Hayashi Atypical adenomatous hyperplasia of the lung: implications for the pathogenesis of peripheral lung adenocarcinoma Am J Clin Pathol 111 1999 610 622
28. H. Kitamura, Y. Kameda, and N. Nakamura Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma Am J Pathol 146 1995 876 887
29. K. Okudela, H. Hayashi, and T. Ito KRAS gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cell via Akt activation: possible contribution to non-invasive expression of lung adenocarcinoma Am J Pathol 164 2004 91 100
30. K. Okudela, T. Yazawa, and T. Woo Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis Am J Pathol 175 2009 867 881
31. M.M. Cloutier, D.A. Shaeffer, and D. Hight Congenital cystic adenomatoid malformation Cancer 75 1995 2844 2852
32. Y.S. Kwon, W.J. Koh, and J. Han Clinical characteristics and feasibility of thoracoscopic approach for congenital cystic adenomatoid malformation in adults Eur J Cardiothorac Surg 31 2007 797 801
33. S. Lantuejoul, A.G. Nichlson, and G. Sartori Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors Am J Surg Pathol 31 2007 961 969
34. T. Kosaka, Y. Yatabe, and H. Endoh Mutations of the epidermal growth factor receptor gene in the lung cancer: biological and clinical implications Cancer Res 64 2004 8919 8923